Logo_Blue_M.Biologics

Magellan Biologics & Consulting

Discover new horizons
in Transient Protein
Expression

History

The Magellan Biologics and Consulting history starts in 2014, when a Group of renowned experts in protein expression in mammalian cells from ExcellGene, a Contract Development and Manufacturing Organization, decide to offer their expertise to the scientific community involved in discovery and pre-clinical development projects. A new company is thus established in Portugal, headquartered in Torres Novas and given the name of the most famous Portuguese explorer Magellan.

Through their first consulting mandates, between Year 2015 and Year 2019, the founders recognize the need from a fast-growing number of R&D labs worldwide to develop their own capacity to produce in-house large varieties of candidate proteins to feed their screening programs. Based on the knowledge acquired at ExcellGene, on its proprietary processes and cell lines and through an exclusive licensing agreement Magellan Biologics and Consulting starts its laboratory operations in 2019, first with the Institute for Research and Innovation in Health in Porto and then, since 2021 at Biocant, the Portugal Science & Technology Park for Biotech and Life Science in Cantanhede, in the Coimbra region.

As a first fruit of a joint R&D program between ExcellGene and Magellan, CHO 4Tx®, a revolutionary ready-to-use transfection kit for CHO cells is launched in 2022 and commercialized to support the scientific community discovering new horizons in Transient Protein Expression.

Vision

The therapeutic and diagnostic role of recombinant proteins is expanding in a growing number of applications, strongly contributing to medical progress in more and more life-threatening conditions. The discovery stage, which aim is to identify new candidates for further clinical development, is the first key to successful R&D programs and the phase for Magellan’s know-how and products to make a difference. By accelerating basic and applied research we’re willing to contribute to improve and save patients’ lives.

Mission

We make Protein Expression in mammalian cells easy and efficient for the benefit of the international scientific community involved in R&D on candidate proteins either for therapeutic or diagnostic use.

Values

Science

Professional

– Expertise
– Scientific mind
– Transparency

Service

Proactive & Responsive

– Self-challenging
and self-improving
– Openness
– Helpfulness

Progress

Innovative & Pragmatic

– Continuous process 
and product development
– Solution-oriented

Fields of Activity

Science

Service

Progress

Creative & Methodical

Proactive

Innovative & Pragmatic

– Expertise
– Scientific mindset
– Transparency

– Self-challenging
and self-improving
– Openness
– Helpfulness

– Continuous process 
and product development
– Solution-oriented
– Result-oriented

Team

Dr. Maria Wurm
Founder and Chief Executive Officer

Prof Florian Wurm
Founder and Chief Scientific Officer

Jérôme Puginier, MSc
Head of Business Development and commercial operations

Vanessa Fernandes, MSc Research associate

Ana Santos, Ing
Managing Director

Dr. Artur Rodrigues
Laboratory Manager

Fields of Activity

Manufacturing and sales of CHO 4Tx® – ready to use transfection kit for in-house production of proteins

Advising and training to our clients willing to set up a transient protein expression unit in their own lab (protocols, technique, materials and equipment)

Production of small volumes of proteins from DNA through ExcellGene’s proprietary transfection system (CHO 4Tx® cells and CHO 4Tx® transfection kit)

Magellan Biologics & Consulting Lda.
Rua da Fábrica nº 37, 1º
2350-761Torres Novas, Portugal

Laboratory
Biocant Park -Parque Tecnológico de Cantanhede
Edifício III – Laboratório 5
3060-197 Cantanhede, Portugal

+351 911 004 699
+351 231 249 290

 

Welcome on board!

Subscribe to our Newsletter
and stay updated!

Get Updates!

If you opt in above we use this information send related content